The authors suggested CSC-derived exo-SNHG16 promoted cancer progression by activating TLR7/MyD88/NFκB/c-Myc signaling pathway.
[Stem Cell Research & Therapy]
Sorry, but the selected Zotpress account can't be found.
Sorry, but the selected Zotpress account can't be found.